Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated … B Dahlbäck, M Carlsson, PJ Svensson Proceedings of the National Academy of Sciences 90 (3), 1004-1008, 1993 | 2857 | 1993 |
Resistance to activated protein C as a basis for venous thrombosis PJ Svensson, B Dahlback New England Journal of Medicine 330 (8), 517-522, 1994 | 1618 | 1994 |
Blood coagulation B Dahlbäck The Lancet 355 (9215), 1627-1632, 2000 | 1161 | 2000 |
Inherited thrombophilia: part 1 DA Lane, PM Mannucci, KA Bauer, RM Bertina, NP Bochkov, ... Thrombosis and haemostasis 76 (11), 651-662, 1996 | 1055 | 1996 |
Geographic distribution of the 20210 G to A prothrombin variant FR Rosendaal, CJM Doggen, A Zivelin, VR Arruda, M Aiach, DS Siscovick, ... Thrombosis and haemostasis 79 (04), 706-708, 1998 | 1009 | 1998 |
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M C Christoffersen, H Obinata, SB Kumaraswamy, S Galvani, J Ahnström, ... Proceedings of the National Academy of Sciences 108 (23), 9613-9618, 2011 | 647 | 2011 |
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. B Zöller, PJ Svensson, X He, B Dahlbäck The Journal of clinical investigation 94 (6), 2521-2524, 1994 | 603 | 1994 |
Thrombotic risk during pregnancy: a population study P Lindqvist, B Dahlbäck, K Marŝál Obstetrics & Gynecology 94 (4), 595-599, 1999 | 567 | 1999 |
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis B Zöller, B Dahlbäck The Lancet 343 (8912), 1536-1538, 1994 | 558 | 1994 |
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis A Angelillo-Scherrer, PG de Frutos, C Aparicio, E Melis, P Savi, F Lupu, ... Nature medicine 7 (2), 215-221, 2001 | 546 | 2001 |
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 544 | 2001 |
High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. B Dahlbäck, J Stenflo Proceedings of the National Academy of Sciences 78 (4), 2512-2516, 1981 | 517 | 1981 |
Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system B Dahlbäck Thrombosis and haemostasis 66 (07), 049-061, 1991 | 516 | 1991 |
Inactivation of human coagulation factor V by activated protein C. K Suzuki, J Stenflo, B Dahlbäck, B Teodorsson Journal of Biological Chemistry 258 (3), 1914-1920, 1983 | 516 | 1983 |
The protein C anticoagulant system: inherited defects as basis for venous thrombosis B Dahlbäck Thrombosis research 77 (1), 1-43, 1995 | 509* | 1995 |
Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. B Dahlbäck, B Hildebrand Proceedings of the National Academy of Sciences 91 (4), 1396-1400, 1994 | 497 | 1994 |
Advances in understanding pathogenic mechanisms of thrombophilic disorders B Dahlbäck Blood, The Journal of the American Society of Hematology 112 (1), 19-27, 2008 | 490 | 2008 |
Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism B Dahlback | 470 | 1995 |
Gas6 and protein S: vitamin K‐dependent ligands for the Axl receptor tyrosine kinase subfamily S Hafizi, B Dahlbäck The FEBS journal 273 (23), 5231-5244, 2006 | 463 | 2006 |
A novel human apolipoprotein (apoM) N Xu, B Dahlbäck Journal of Biological Chemistry 274 (44), 31286-31290, 1999 | 459 | 1999 |